On its second-quarter fiscal 2027 earnings call, held on Oct. 14, 2026, Sono-Tek (NASDAQ:SOTK) announced that first-half revenue rose 6% to $10.9 million as medical market sales nearly quadrupled. This transition toward higher-value production systems should help expand profit margins and secure multiyear order visibility for shareholders. Three key takeaways from management explain how this strategic evolution shapes the company's long-term outcome. Medical market revenue surged 289% to $7.1 million during the first half of fiscal 2027. This growth matters because clients are advancing beyond initial process development into commercial manufacturing, where systems command a higher average selling price (ASP), or unit price, and generate attractive gross profit margins.
CryptoAlerta — análise de criptomoedas e mercado em tempo real